No Cover Image

Journal article 725 views 151 downloads

Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk

Mansoor Husain, Steve Bain Orcid Logo, Ole K. Jeppesen, Ildiko Lingvay, Rasmus Sørrig, Marianne B. Treppendahl, Tina Vilsbøll

Diabetes, Obesity and Metabolism, Volume: 22, Issue: 3, Pages: 442 - 451

Swansea University Author: Steve Bain Orcid Logo

  • 53094.pdf

    PDF | Version of Record

    Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).

    Download (950.96KB)

Check full text

DOI (Published version): 10.1111/dom.13955

Published in: Diabetes, Obesity and Metabolism
ISSN: 1462-8902 1463-1326
Published: Wiley 2020
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa53094
first_indexed 2020-01-06T19:57:54Z
last_indexed 2020-10-24T03:05:22Z
id cronfa53094
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2020-10-23T11:08:29.0757931</datestamp><bib-version>v2</bib-version><id>53094</id><entry>2020-01-02</entry><title>Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2020-01-02</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Diabetes, Obesity and Metabolism</journal><volume>22</volume><journalNumber>3</journalNumber><paginationStart>442</paginationStart><paginationEnd>451</paginationEnd><publisher>Wiley</publisher><issnPrint>1462-8902</issnPrint><issnElectronic>1463-1326</issnElectronic><keywords>cardiovascular disease, clinical trial, glucagon-like peptide-1 analogue, phase III study, type 2 diabetes</keywords><publishedDay>1</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-03-01</publishedDate><doi>10.1111/dom.13955</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-10-23T11:08:29.0757931</lastEdited><Created>2020-01-02T15:40:47.1648772</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Mansoor</firstname><surname>Husain</surname><order>1</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>2</order></author><author><firstname>Ole K.</firstname><surname>Jeppesen</surname><order>3</order></author><author><firstname>Ildiko</firstname><surname>Lingvay</surname><order>4</order></author><author><firstname>Rasmus</firstname><surname>S&#xF8;rrig</surname><order>5</order></author><author><firstname>Marianne B.</firstname><surname>Treppendahl</surname><order>6</order></author><author><firstname>Tina</firstname><surname>Vilsb&#xF8;ll</surname><order>7</order></author></authors><documents><document><filename>53094__16630__2ec6aaedac714551b565c29805bcf150.pdf</filename><originalFilename>53094.pdf</originalFilename><uploaded>2020-02-19T15:24:23.1545377</uploaded><type>Output</type><contentLength>973784</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by-nc/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling 2020-10-23T11:08:29.0757931 v2 53094 2020-01-02 Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2020-01-02 MEDS Journal Article Diabetes, Obesity and Metabolism 22 3 442 451 Wiley 1462-8902 1463-1326 cardiovascular disease, clinical trial, glucagon-like peptide-1 analogue, phase III study, type 2 diabetes 1 3 2020 2020-03-01 10.1111/dom.13955 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2020-10-23T11:08:29.0757931 2020-01-02T15:40:47.1648772 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Mansoor Husain 1 Steve Bain 0000-0001-8519-4964 2 Ole K. Jeppesen 3 Ildiko Lingvay 4 Rasmus Sørrig 5 Marianne B. Treppendahl 6 Tina Vilsbøll 7 53094__16630__2ec6aaedac714551b565c29805bcf150.pdf 53094.pdf 2020-02-19T15:24:23.1545377 Output 973784 application/pdf Version of Record true Released under the terms of a Creative Commons Attribution-NonCommercial License (CC-BY-NC). true eng http://creativecommons.org/licenses/by-nc/4.0/
title Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
spellingShingle Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
Steve Bain
title_short Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
title_full Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
title_fullStr Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
title_full_unstemmed Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
title_sort Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Mansoor Husain
Steve Bain
Ole K. Jeppesen
Ildiko Lingvay
Rasmus Sørrig
Marianne B. Treppendahl
Tina Vilsbøll
format Journal article
container_title Diabetes, Obesity and Metabolism
container_volume 22
container_issue 3
container_start_page 442
publishDate 2020
institution Swansea University
issn 1462-8902
1463-1326
doi_str_mv 10.1111/dom.13955
publisher Wiley
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2020-03-01T02:05:51Z
_version_ 1822365897592930304
score 11.048453

Similar Items